Chrome Extension
WeChat Mini Program
Use on ChatGLM

Two-year Follow-Up Data on the Efficacy and Safety of KN026, a HER2-targeted Bispecific Antibody Combined with Docetaxel As First-Line Treatment for HER2-positive Recurrent/metastatic Breast Cancer

ANNALS OF ONCOLOGY(2023)

Cited 0|Views25
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined